Meetings
The HCV Forum convenes once a year to discuss emerging issues in the field of HCV drug development. See below for more information on the most recent HCV Forum meeting.
MAR-30-11 The Sixth HCV Drug Development Advisory Group Meeting: Issues in Clinical Trial Design with DAAs was held to discuss a number of topics including issues in deep sequencing technologies and its possible clinical utility; development of a HCV drug resistance table and chart to facilitate drug resistance monitoring; a proposal for new clinical trial related definitions and nomenclature; issues in DAA combination trials; considerations for trials in HIV/HCV co-infected patients and in liver transplant patients; and ethical and feasibility issues in conducting trials in countries where new DAAs are approved or available.
Read more »
|
|